Skip to content

Glaucoma Eye Care

Active Private limited companyfounded 2023active for 2 yearsSnoy et d'Oppuerslaan 19, 3020 HerentKBO/BCE: BE 1003.663.552

Board

1 director, since incorporation
Director (not named in the articles)
since 20-12-2023 term without a fixed end
listed in the 2025 annual accounts, filed on 20-03-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 22-12-2023

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director (not named in the articles)
Board
Mandates as a list
    • Director (not named in the articles), from 20-12-2023 to date

Control

Founder
This company
Glaucoma Eye Care
Equity €271,853
Profit €211,089 in 2025

Capital

Contribution
€2,500
Shares
120
Contribution per share
€20.83
Equity per share
€2,265 in 2025
Source
deed of 22-12-2023

Articles of association

deed of 22-12-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
Geheel of gedeeltelijk herroepbaar om gewichtige redenen bij besluit algemene vergadering met vereisten statutenwijziging, één of meer bestuurders,artsen-aandee…
Onbezoldigd tenzij anders beslist door algemene vergadering, werkverdeling,alle vergoedingen inclusief bezoldiging bestuurder en terugbetalingen kosten en vacat…
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
Voor overdracht medische dossiers bijgestaan door arts, een of meerdere vereffenaars aanduiden,bevoegdheden omlijnen,vergoeding bepalen

Shareholders

At incorporation deed of 22-12-2023 ↗
  • 120 shares (100%) · €2,500

Next steps